Showing posts with the label Covid-19 Vaccine.
3 minutes - Source: CNBC Jakub Porzycki | NurPhoto | Getty Images British drugmaker AstraZeneca has begun testing an antibody-based cocktail for the prevention and treatment of Covid-19, adding to recent signs of progress on possible medical solutions to the disease caused by the novel coronavirus. The London-listed firm, already among the leading players in the global race to develop a successful vaccine, said the study would evaluate if AZD7442, a combination of two monoclonal antibodies (mAbs), was safe and tolerable in up to 48 healthy participants between the ages of 18 and 55 years. If the U.K.-based early-stage trial, which has dosed its participants, shows AZD7442 is safe, AstraZeneca said it would proceed to test it as both a preventative treatment for Covid-19 and a medicine for patients who have it, in larger, mid-to-late-stage studies. AstraZeneca shares were up about 1% at 87 pounds ($114) in early trading. Development